Sign up to save your podcasts
Or
Share SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists
Dr. Jeff Burns, Director of the University of Kansas Alzheimer's Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease.
View all episodes
By American Academy of Neurology
4.7
285285 ratings
Dr. Jeff Burns, Director of the University of Kansas Alzheimer's Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease.
More shows like Neurology® Podcast
View all
NEJM This Week
320 Listeners
JAMA Clinical Reviews
497 Listeners
Practical Neurology Podcast
50 Listeners
The Curbsiders Internal Medicine Podcast
3,341 Listeners
JAMA Neurology Author Interviews
12 Listeners
Core IM | Internal Medicine Podcast
1,149 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
513 Listeners
Neurology Minute
134 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Neurology Exam Prep Podcast
189 Listeners
The Curious Clinicians
373 Listeners
Ninja Nerd
316 Listeners
Continuum Audio
82 Listeners